SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001318641-18-000042
Filing Date
2018-11-14
Accepted
2018-11-14 08:24:23
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbli-093018x10q.htm 10-Q 699015
2 EXHIBIT 31.1 cbli-093018xex311.htm EX-31.1 13328
3 EXHIBIT 32.1 cbli-093018xex321.htm EX-32.1 8085
  Complete submission text file 0001318641-18-000042.txt   3890781

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cbli-20180930.xml EX-101.INS 713268
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbli-20180930.xsd EX-101.SCH 34115
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cbli-20180930_cal.xml EX-101.CAL 46426
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbli-20180930_def.xml EX-101.DEF 172725
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbli-20180930_lab.xml EX-101.LAB 487474
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbli-20180930_pre.xml EX-101.PRE 278392
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32954 | Film No.: 181180510
SIC: 8731 Services-Commercial Physical & Biological Research